-
1Academic Journal
المؤلفون: Peñata, Adrián, Mesa, Santiago, Leal, Ana, Castaño, Tatiana, Bustamante, Julián, Sigifredo, Ospina
المصدر: Revista do Instituto de Medicina Tropical de São Paulo. January 2020 62
مصطلحات موضوعية: Meningitis, Meningoencephalitis, Diagnosis, Multiplex PCR, Colombia
وصف الملف: text/html
-
2Academic Journal
المصدر: Ciencias Sociales y Educación; Vol. 12 No. 24 (2023): (July-december); 409-438 ; Ciencias Sociales y Educación; Vol. 12 Núm. 24 (2023): (julio-diciembre); 409-438 ; 2590-7344 ; 2256-5000
مصطلحات موضوعية: Job satisfaction, status, working conditions, freelance work, precarious work, public service, professional translators, satisfacción laboral, estatus, condiciones de trabajo, trabajo independiente, trabajo precario, servicio público, traductores profesionales
وصف الملف: application/pdf
-
3Academic Journal
المصدر: Revista de la Facultad de Medicina; Vol. 71 No. 1 (2023); e98079 ; Revista de la Facultad de Medicina; Vol. 71 Núm. 1 (2023); e98079 ; Revista de la Facultad de Medicina; v. 71 n. 1 (2023); e98079 ; 2357-3848 ; 0120-0011
مصطلحات موضوعية: Colombia, Mutación, Reacción en cadena de la polimerasa, Tuberculosis, Rifampicina, Microbiología, Biología molecular, enfermedades infecciosas, Mutation, Polymerase Chain Reaction, Rifampicin, Microbiology, Molecular Biology, Infectious Diseases
وصف الملف: application/pdf; text/html
-
4Academic Journal
المؤلفون: Bustamante, Julian A., Ceron, Josue S., Gao, Ivan Thomas, Ramirez, Hector A., Aviles, Milo V., Bet Adam, Demsin, Brice, Jason R., Cuellar, Rodrigo A., Dockery, Eva, Jabagat, Miguel Karlo, Karp, Donna Grace, Lau, Joseph Kin-On, Li, Suling, Lopez-Magaña, Raymondo, Moore, Rebecca R., Morin, Bethany Kristi R., Nzongo, Juliana, Rezaeihaghighi, Yasha, Sapienza-Martinez, Joseph, Tran, Tuyet Thi Kim, Huang, Zhenzhong, Duthoy, Aaron J., Barnett, Melanie J., Long, Sharon R., Chen, Joseph C.
المساهمون: Shen, Aimee, National Institute of General Medical Sciences, Division of Integrative Organismal Systems, Division of Biological Infrastructure, Arnold and Mabel Beckman Foundation
المصدر: PLOS Genetics ; volume 19, issue 10, page e1010776 ; ISSN 1553-7404
-
5Academic Journal
المؤلفون: Brainard, Scott H., Bustamante, Julian A., Dawson, Julie C., Spalding, Edgar P., Goldman, Irwin L.
المساهمون: National Science Foundation, Agricultural Research Service
المصدر: Frontiers in Plant Science ; volume 12 ; ISSN 1664-462X
-
6Electronic Resource
المؤلفون: Peñata Bedoya, Adrián, Pérez, Camilo, Castaño Sepúlveda, Tatiana, Bustamante, Julián, Ospina, Sigifredo
المصدر: Revista de la Facultad de Medicina, ISSN 2357-3848, Vol. 71, Nº. 1, 2023, pags. 52-60
-
7Academic Journal
المؤلفون: Irnov, Irnov, Wang, Zhe, Jannetty, Nicholas D., Bustamante, Julian A., Rhee, Kyu Y., Jacobs-Wagner, Christine
المساهمون: Casadesús, Josep, National Institutes of Health, Burroughs Wellcome Fund, Howard Hughes Medical Institute
المصدر: PLOS Genetics ; volume 13, issue 8, page e1006978 ; ISSN 1553-7404
-
8Electronic Resource
Additional Titles: Distribución y frecuencia de potenciales mutaciones asociadas con la resistencia a rifampicina en el gen rpoB de Mycobacterium tuberculosis detectadas mediante un método molecular automatizado
المؤلفون: Peñata, Adrian, Pérez, Camilo, Castaño, Tatiana, Bustamante, Julián, Ospina, Sigifredo
المصدر: Revista de la Facultad de Medicina; Vol. 71 Núm. 1 (2023): Publicación preliminar; e98079; Revista de la Facultad de Medicina; Vol. 71 No. 1 (2023): In Press Publication; e98079; Revista de la Facultad de Medicina; v. 71 n. 1 (2023): Publicación preliminar; e98079; 2357-3848; 0120-0011
مصطلحات الفهرس: Colombia, Mutation, Polymerase Chain Reaction, Tuberculosis, Rifampicin, Microbiology, Molecular Biology, Infectious Diseases, Mutación, Reacción en cadena de la polimerasa, Rifampicina, Microbiología, Biología molecular, enfermedades infecciosas, Enfermedades infecciosas, info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion, Original research, Investigación original, Investigação original
URL:
https://revistas.unal.edu.co/index.php/revfacmed/article/view/98079/82853 https://revistas.unal.edu.co/index.php/revfacmed/article/view/98079/82853
*ref*/World Health Organization. Global tuberculosis report 2021. Geneva. [Fecha de consulta: enero 22 de 2022] Disponible en: https://www.who.int/publications/i/item/9789240037021
*ref*/Instituto Nacional de Salud. Boletín Epidemiológico Semanal, semana epidemiológica 11 del 2019. [Fecha de consulta: enero 18 de 2021]. Disponible en: https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2019%20Bolet%C3%ADn%20epidemiol%C3%B3gico%20semana%2011.pdf
*ref*/Instituto Nacional de Salud. Informe del Evento Tuberculosis Farmacorresistente, Colombia, 2018. [Fecha de consulta: abril 24 de 2021]. Disponible en: https://www.ins.gov.co/buscador-eventos/Informesdeevento/TUBERCULOSIS%20FARMACORRESISTENTE_2018.pdf
*ref*/Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis. 1998;79(1):3–29. https://dx.doi.org/10.1054/tuld.1998.0002
*ref*/Adikaram CP, Perera J, Wijesundera SS. Geographical profile of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis isolates in Sri Lanka. Microb Drug Resist. 2012 Oct;18(5):525–30. https://dx.doi.org/10.1089/mdr.2012.0031
*ref*/World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system. Geneva, Switzerland.; 2011. [Fecha de consulta: abril 24 de 2021]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/44586/9789241501545_eng.pdf?sequence=1&isAllowed=y
*ref*/Canetti G, Froman S, Grosset J, Hauduroy P, Langerova M, Mahler HT, et al. MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE. Bull World Health Organ. 1963;29:565–78.
*ref*/Peñata A, Salazar R, Castaño T, Bustamante J, Ospina S. Molecular diagnosis of extrapulmonary tuberculosis and sensitivity to rifampicin with an automated real-time method. Biomédica. 2016 Apr 1;36:78–89. https://dx.doi.org/10.7705/biomedica.v36i3.3088
*ref*/WMA Declaration of Helsinki. Ethical principles for medical research involving human subjects. Fortaleza: 64th WMA General Assembly [Internet]. [Fecha de consulta: noviembre 18 de 2021]. Disponible en: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects
*ref*/Ministerio de Salud de Colombia. Resolución 8430 de 1993. Por la cual se establecen las normas científicas, técnicas y administrativas para la investigación en salud. [Fecha de consulta: octubre 22 de 2021]. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/RESOLUCION-8430-DE-1993.PDF
*ref*/Mesfin YM, Hailemariam D, Biadglign S, Kibret KT. Association between HIV/AIDS and Multi-Drug Resistance Tuberculosis: A Systematic Review and Meta-Analysis. PLoS One. 2014 Jan 8;9(1):e82235. https://dx.doi.org/10.1371/journal.pone.0082235
*ref*/World Health Organization. Planning for country transition to Xpert® MTB/RIF Ultra cartridges, 2017. WHO Technical Expert Consultation. [Fecha de consulta: abril 24 de 20201]. Disponible en: http://www.stoptb.org/wg/gli/assets/documents/gli_ultra.pdf
*ref*/Chonde TM, Basra D, Mfinanga SGM, Range N, Lwilla F, Shirima RP, et al. National anti-tuberculosis drug resistance study in Tanzania. Int J Tuberc Lung Dis. 2010 Aug;14(8):967–72
*ref*/Ochang EA, Udoh UA, Emanghe UE, Tiku GO, Offor JB, Odo M, et al. Evaluation of rifampicin resistance and 81-bp rifampicin resistant determinant region of rpoB gene mutations of Mycobacterium tuberculosis detected with XpertMTB/Rif in Cross River State, Nigeria. Int J Mycobacteriology. 2016;5:S145–6. https://dx.doi.org/10.1016/j.ijmyco.2016.09.007
*ref*/Ullah I, Shah AA, Basit A, Ali M, khan A, Ullah U, et al. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study. BMC Infect Dis. 2016;16:413. https://dx.doi.org/10.1186/s12879-016-1745-2
*ref*/Mboowa G, Namaganda C, Ssengooba W. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert®MTB/RIF in Kampala, Uganda: a retrospective study. BMC Infect Dis. 2014;14:481. https://dx.doi.org/10.1186/1471-2334-14-481
*ref*/Ferro BE, García PK, Nieto LM, van Soolingen D. Predictive value of molecular drug resistance testing of Mycobacterium tuberculosis isolates in Valle del Cauca, Colombia. J Clin Microbiol. 2013;51(7):2220–4. https://dx.doi.org/10.1128/JCM.00429-13
*ref*/Llerena C, Medina R. Description of Mycobacterium tuberculosis mutations conferring resistance to rifampicin and isoniazid detected by GenoType® MTBDRplus V.2 in Colombia. Biomédica. 2017;37(1):28–33. https://dx.doi.org/10.7705/biomedica.v37i1.3174
*ref*/Zetola NM, Shin SS, Tumedi KA, Moeti K, Ncube R, Nicol M, et al. Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes. J Clin Microbiol. 2014;52(7):2422–9. https://dx.doi.org/10.1128/JCM.02489-13
*ref*/Asencios L, Galarza M, Quispe N, Vásquez L, Leo E, Valencia E, et al. Prueba molecular genotype® MTBDRplus, una alternativa para la detección rápida de tuberculosis multidrogorresistente. Rev Peru Med Exp Salud Pública. 2012;29(1):92-98
*ref*/Araya P, Velasco M, Tognarelli J, Arias F, Leiva T, Sccapatticio A, et al. Detección de mutaciones asociadas a cepas multidrogo resistente de Mycobacterium tuberculosis en Chile. Rev Med Chile. 2011;139(4):467–73. http://dx.doi.org/10.4067/S0034-98872011000400008
*ref*/Alemu A, Tadesse M, Seid G, Mollalign H, Eshetu K, Sinshaw W, et al. Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia. BMC Infect Dis. 2020;20(1):87. http://dx.doi.org/10.1186/s12879-020-4817-2
*ref*/Reddy R, Alvarez-Uria G. Molecular Epidemiology of Rifampicin Resistance in Mycobacterium tuberculosis Using the GeneXpert MTB/RIF Assay from a Rural Setting in India. J Pathog. 2017;2017:6738095. http://dx.doi.org/10.1155/2017/6738095
*ref*/Chikaonda T, Ketseoglou I, Nguluwe N, Krysiak R, Thengolose I, Nyakwawa F, et al. Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Malawi. Afr J Lab Med. 2017;6(2):463. https://dx.doi.org/10.4102/ajlm.v6i2.463
*ref*/Uddin MKM, Rahman A, Ather MF, Ahmed T, Rahman SMM, Ahmed S, et al. Distribution and Frequency of rpoB Mutations Detected by Xpert MTB/RIF Assay Among Beijing and Non-Beijing Rifampicin Resistant Mycobacterium tuberculosis Isolates in Bangladesh. Infect Drug Resist. 2020;13:789–97. https://dx.doi.org/10.2147/IDR.S240408
*ref*/Mathys V, van de Vyvere M, de Droogh E, Soetaert K, Groenen G. False-positive rifampicin resistance on Xpert® MTB/RIF caused by a silent mutation in the rpoB gene. Int J Tuberc Lung Dis. 2014;18(10):1255–7. https://dx.doi.org/10.5588/ijtld.14.0297.
*ref*/Williamson DA, Roberts SA, Bower JE, Vaughan R, Newton S, Lowe O, et al. Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2012;16(2):216–20. https://dx.doi.org/10.5588/ijtld.11.0178
*ref*/Somoskovi A, Deggim V, Ciardo D, Bloemberg GV. Diagnostic Implications of Inconsistent Results Obtained with the Xpert MTB/Rif Assay in Detection of Mycobacterium tuberculosis Isolates with an rpoB Mutation Associated with Low-Level Rifampin Resistance. J Clin Microbiol. 2013;51(9):3127–9. https://dx.doi.org/10.1128/JCM.01377-13. https://dx.doi.org
*ref*/Rufai SB, Kumar P, Singh A, Prajapati S, Balooni V, Singh S. Comparison of Xpert MTB/RIF with Line Probe Assay for Detection of Rifampin-Monoresistant Mycobacterium tuberculosis. J Clin Microbiol. 2014;52(6):1846–52. https://dx.doi.org/10.1128/JCM.03005-13 -
9Academic Journal
المؤلفون: Suárez, Luz M, Muñoz, María-Dolores, González, José C, Bustamante, Julián, Del Río, Rafael Martín, Solís, José M
المساهمون: Instituto de Salud Carlos III
مصطلحات موضوعية: Glutamate, Nutrition, Osmoresistant, Osmosensitive, Rat
Relation: Amino acids; Publisher's version; https://doi.org/10.1016/j.nbd.2023.106278; Sí; http://hdl.handle.net/10261/345013; http://dx.doi.org/10.13039/501100004587; 2-s2.0-84978877089; https://api.elsevier.com/content/abstract/scopus_id/84978877089
-
10Dissertation/ Thesis
المؤلفون: Zegarra Bustamante, Julian Eduardo
المساهمون: Salinas Salas, Alfredo Mauricio
المصدر: Universidad Católica San Pablo ; Repositorio Institucional - UCSP
مصطلحات موضوعية: Clima organizacional, Marca interna, Colaborador, Gestión, Desarrollo, http://purl.org/pe-repo/ocde/ford#5.00.00
وصف الملف: application/pdf
Relation: 1078385; https://hdl.handle.net/20.500.12590/17544
-
11Academic Journal
Alternate Title: Distribución y frecuencia de potenciales mutaciones asociadas con la resistencia a rifampicina en el gen rpoB de Mycobacterium tuberculosis detectadas mediante un método molecular automatizado. (Spanish)
المصدر: Revista Facultad de Medicina de la Universidad Nacional de Colombia; 2023, Vol. 71 Issue 1, p1-9, 9p
مصطلحات موضوعية: MULTIDRUG-resistant tuberculosis, MYCOBACTERIUM tuberculosis, MOLECULAR biology, RIFAMPIN, GENETIC mutation, TUBERCULOSIS
مصطلحات جغرافية: MEDELLIN (Colombia), COLOMBIA
-
12Academic Journal
المؤلفون: Suárez, Luz M, Bustamante, Julián, Orensanz, Luís M, Martín del Río, Rafael, Solís, José M
المساهمون: Ministerio de Ciencia e Innovación (España)
Relation: Neuropharmacology; Publisher's version; https://doi.org/10.1016/j.nbd.2023.106278; Sí; http://hdl.handle.net/10261/345016; http://dx.doi.org/10.13039/501100004837; 2-s2.0-84890110115; https://api.elsevier.com/content/abstract/scopus_id/84890110115
-
13Academic Journal
المؤلفون: Mostafavi, Mina, Lewis, Jainee Christa, Saini, Tanisha, Bustamante, Julian Albert, Gao, Ivan Thomas, Tran, Tuyet Thi, King, Sean Nicholas, Huang, Zhenzhong, Chen, Joseph C
المصدر: BMC Microbiology ; volume 14, issue 1 ; ISSN 1471-2180
الاتاحة: http://dx.doi.org/10.1186/s12866-014-0295-2
http://link.springer.com/article/10.1186/s12866-014-0295-2/fulltext.html
http://link.springer.com/content/pdf/10.1186/s12866-014-0295-2.pdf
http://link.springer.com/content/pdf/10.1186/s12866-014-0295-2
https://link.springer.com/content/pdf/10.1186/s12866-014-0295-2.pdf -
14Dissertation/ Thesis
المساهمون: Ricci, María Beatriz
مصطلحات موضوعية: Recesión, Intención de compra, Consumo ecológico, Comportamiento ecológico, Crisis económica, Argentina, Consumo, Productos ecológicos
Relation: http://hdl.handle.net/11086/12717
الاتاحة: http://hdl.handle.net/11086/12717
-
15Dissertation/ Thesis
المؤلفون: Gómez Bustamante, Julián
المساهمون: Quiroz Higuita, José Iván, Escobar Hernández, Ana Isabel
مصطلحات موضوعية: Documentación, Procesos, Sistema integrado de gestión
وصف الملف: application/pdf
Relation: Gómez Bustamante, J. (2018). Diseño y/o actualización de la documentación de los procesos de la gerencia administrativa y financiera de la empresa personal Soft (Trabajo de grado de pregrado). Universidad de Antioquia. Medellín, Colombia.; http://hdl.handle.net/10495/13150
الاتاحة: http://hdl.handle.net/10495/13150
-
16Electronic Resource
المؤلفون: Gentilin, Mariano, Kepes Bustamante, Julián
-
17
المصدر: Biomédica, Volume: 36 Supplement 1, Pages: 78-89, Published: DEC 2016
مصطلحات موضوعية: tuberculosis miliar, tuberculosis, polymerase chain reaction, ADN, Mycobacterium tuberculosis, DNA, rifampicina, reacción en cadena de la polimerasa, rifampin, miliary
وصف الملف: text/html
-
18Academic Journal
المصدر: Biomedica; Vol. 36 (2016): Suplemento 1, Microbiología médica; 78-89 ; Biomédica; Vol. 36 (2016): Suplemento 1, Microbiología médica; 78-89 ; 2590-7379 ; 0120-4157
مصطلحات موضوعية: Mycobacterium tuberculosis, tuberculosis miliar, reacción en cadena de la polimerasa, ADN, rifampicina, tuberculosis, miliary, polymerase chain reaction, DNA, rifampin
وصف الملف: application/pdf; text/html
Relation: https://revistabiomedica.org/index.php/biomedica/article/view/3088/3061; https://revistabiomedica.org/index.php/biomedica/article/view/3088/3124; World Health Organization. Twentieth global report on tuberculosis. Report number WHO/HTM/TB/2015.22. Geneva: World Health Organization; 2015. Fecha de consulta: 7 de diciembre de 2015. Disponible en: http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf.; Instituto Nacional de Salud. Informe final tuberculosis, Colombia, 2014. Fecha de consulta: 1 de diciembre de 2015. Disponible en: http://www.ins.gov.co/lineas-de-accion/Subdireccion-Vigilancia/Informe%20de%20Evento%20Epidemiolgico/Tuberculosis%202014.pdf.; Lado-Lado FL, Prieto-Martínez A, Cabarcos-Ortiz De Barrón A, Carballo-Arceo E, Barrio-Gómez E. Recurrence of tuberculosis in patients infected with the human immunodeficiency virus. An Med Interna. 2001;18:243-7.; Golden MP, Vikram HR. Extrapulmonary tuberculosis: An overview. Am Fam Physician. 2005;72:1761-8.; Raviglione MC, O´Brien R. Mycobacterial diseases. In: Harrison's Principles of Internal Medicine. 18th edition. New York: McGraw-Hill; 2012. p. 1340-59.; Hesselink DA, Yoo SM, Verhoeven GT, Brouwers JW, Smit FJ, van Saase JL. A high prevalence of culture-positive extrapulmonary tuberculosis in a large Dutch teaching hospital. Neth J Med. 2003;61:65-70.; Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999;282:677-86. http://dx.doi.org/10.1001/jama.282.7.677.; Pacheco M, Awad C, Arias G, Ojeda P, Garay M, Lara A, et al. Extrapulmonary tuberculosis. A perspective from a third-level hospital. Rev Colomb Neumol. 2013;25:16-26.; Canetti G, Rist N, Grosset J. Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation. Rev Tuberc Pneumol (Paris). 1963;27:217-72.; Mishra B, Rockey SM, Gupta S, Srinivasa H, Muralidharan S. Multi-drug-resistant tuberculosis: The experience of an urban tertiary care hospital in South India using automated BACTEC 460 TB. Trop Doct. 2012;42:35-7. http://dx.doi.org/10.1258/td.2011.110247.; Skenders GK, Holtz TH, Riekstina V, Leimane V. Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia. Int J Tuberc Lung Dis. 2011;15:1546-52. http://dx.doi.org/10.5588/ijtld.11.0067.; Barnard M, Gey van Pittius NC, van Helden PD, Bosman M, Coetzee G, Warren RM. The diagnostic performance of the GenoType MTBDRplus version 2 line probe assay is equivalent to that of the Xpert MTB/RIF assay. J Clin Micro-biol. 2012;50:3712-6. http://dx.doi.org/10.1128/JCM.01958-12.; Bicmen C, Gunduz AT, Coskun M, Senol G, Cirak AK, Ozsoz A. Molecular detection and identification of Mycobacterium tuberculosis complex and four clinically important nontuberculous mycobacterial species in smear-negative clinical samples by the genotype mycobacteria direct test. J Clin Microbiol. 2011;4:2874-8. http://dx.doi.org/10.1128/JCM.00612-11.; Lawn SD, Nicol MP. Xpert® MTB/RIF assay: Development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol. 2011;6:1067-82. http://dx.doi.org/10.2217/fmb.11.84.; Blakemore R, Nabeta P, Davidow AL, Vadwai V, Tahirli R, Munsamy V, et al. A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay. Am J Respir Crit Care Med. 2011;184:1076-84. http://dx.doi.org/10.1164/rccm.201103-0536OC.; World Health Organization. Report of the Tenth Meeting WHO Strategic and Technical Advisory Group for Tuberculosis (STAGTB), 27-29 September, 2010. Geneva, World Health Organization; 2010. Fecha de consulta: 30 de noviembre de 2015. Disponible en: http://www.who.int/tb/advisory_bodies/stag_tb_report_2015.pdf?ua=1.; Centers for Disease Control and Prevention. Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. Morb Mortal Wkly Rep. 2009;58:7-10.; Lawn SD, Zumla AI. Diagnosis of extrapulmonary tuberculosis using the Xpert(®) MTB/RIF assay. Expert Rev Anti Infect Ther. 2012;10:631-5. http://dx.doi.org/10.1586/eri.12.43.; Scott LE, Beylis N, Nicol M, Nkuna G, Molapo S, Berrie L, et al. The diagnostic accuracy of Xpert MTB/RIF on extrapulmonary tuberculosis specimens: Establishing a laboratory testing algorithm for South Africa. J Clin Microbiol. 2014;52:1818-23. http://dx.doi.org/10.1128/JCM.03553-13.; Tortoli E, Russo C, Piersimoni C, Mazzola E, Dal Monte P, Pascarella M, et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J. 2012;40:442-7. http://dx.doi.org/10.1183/09031936.00176311.; World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance. Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: Policy update. Geneva: World Health Organization; 2013. Fecha de consulta: 16 de septiembre de 2015. Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK258608/.; Organización Panamericana de la Salud. Manual para el diagnóstico bacteriológico de la tuberculosis. Parte 2, cultivo. Washington, D.C.: OPS; 2008.; Marín DC, Aristizábal BH. Métodos diagnósticos moleculares en tuberculosis. Med UPB. 2013;32:144-50.; Vadwai V, Boehme CC, Nabeta P. A new pillar in diagnosis of extrapulmonary tuberculosis? Clin Microbiol. 2011;49:2540-5. http://dx.doi.org/10.1128/JCM.02319-10.; Montúfar FE, Aguilar-Londoño C, Saldarriaga-Acevedo C, Quiroga-Echeverri A, Montaño B, et al. Características clínicas, factores de riesgo y perfil de susceptibilidad de las infecciones por micobacterias documentadas por cultivo, en un hospital universitario de alta complejidad en Medellín (Colombia). Rev Chil Infectol. 2014;31:735-42. http://dx.doi.org/10.4067/S0716-10182014000600015.; Centers for Disease Control and Prevention. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. MMWR Recomm Rep. 2009;58:1-207.; Vittor AY, Garland JM, Gilman RH. Molecular diagnosis of TB in the HIV positive population. Ann Glob Health. 2014; 80:476-85. http://dx.doi.org/10.1016/j.aogh.2015.01.001.; Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, et al. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: A prospective study. PLoS Med. 2011;8:e1001067. http://dx.doi.org/10.1371/journal.pmed.1001067.; Pérez-Guzmán C, Vargas MH, Arellano-Macías M del R, Hernández-Cobos S, García-Ituarte AZ, Serna-Vela FJ. Clinical and epidemiological features of extrapulmonary tuberculosis in a high incidence region. Salud Pública Mex. 2014;56:189-96.; Hussain SF, Irfan M, Abbasi M, Anwer SS, Davidson S, Haqqee R, et al. Clinical characteristics of 110 miliary tuberculosis patients from a low HIV prevalence country. Int J Tuberc Lung Dis. 2004;8:493-9.; Secretaría de Salud de Medellín. Boletín epidemiológico de Medellín. Alcaldía de Medellín; 2014. Fecha de consulta: 30 de noviembre de 2015. Disponible en: https://www.medellin.gov.co/irj/go/km/docs/pccdesign/SubportaldelCiudadano_2/PlandeDesarrollo_0_19/Publicaciones/Shared%20Content/Boletines/Bolet%C3%ADn%20epidemiol%C3%B3gico%204%20de%202015%20-%20Tuberculosis.pdf.; Clemente M, Palacios J, Penedo A, Álvarez M, Velasco Z, Pando A, et al. Accuracy of the Xpert MTB/RIF test for rapid diagnosis of extrapulmonary tuberculosis. Am J Respir Crit Care Med. 2012;185:A4717. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4717.; Causse M, Ruiz P, Gutiérrez-Aroca JB, Casal M. Comparison of two molecular methods for rapid diagnosis of extrapulmonary tuberculosis. J Clin Microbiol. 2011;49: 3065-7. http://dx.doi.org/10.1128/JCM.00491-11.; Realpe T, Mejía G, Zapata E, Barón P, Gómez V, Robledo J. Evaluación del desempeño de una prueba molecular comercial para el diagnóstico de tuberculosis y la resistencia a rifampicina en muestras clínicas. Hechos Microbiológicos. 2014;5:41.; Moure R, Martín R, Alcaide F. Effectiveness of an integrated real-time PCR method for detection of the Mycobacterium tuberculosis complex in smear-negative extrapulmonary samples in an area of low tuberculosis prevalence. J Clin Microbiol. 2012;50:513-5. http://dx.doi.org/10.1128/JCM.06467-11.; Ferreiro L, San José E, Valdés L. Derrame pleural tuberculoso. Arch Bronconeumol. 2014;50:435-43. http://dx.doi.org/10.1016/j.arbres.2013.07.006.; Porcel JM, Palma R, Valdés L, Bielsa S, San-José E, Esquerda A. Xpert® MTB/RIF in pleural fluid for the diagnosis of tuberculosis. Int J Tuberc Lung Dis. 2013;17:1217-9. http://dx.doi.org/10.5588/ijtld.13.0178.; Friedrich SO, von Groote-Bidlingmaier F, Diacon AH. Xpert MTB/RIF assay for diagnosis of pleural tuberculosis. J Clin Microbiol. 2011;49:4341-2. http://dx.doi.org/10.1128/JCM.05454-11.; Rock RB, Olin M, Baker CA, Molitor TW, Peterson PK. Central nervous system tuberculosis: Pathogenesis and clinical aspects. Clin Microbiol Rev. 2008;21:243-61. http://dx.doi.org/10.1128/CMR.00042-07.; Katti MK. Pathogenesis, diagnosis, treatment, and outcome aspects of cerebral tuberculosis. Med Sci Monit. 2004;10:RA215-29.; Denkinger CM, Schumacher SG, Boehme CC, Dendukuri N, Pai M, Steingart KR. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: A systematic review and meta-analysis. Eur Respir J. 2014;44:435-46. http://dx.doi.org/10.1183/09031936.00007814.; González-Martín J, García-García JM, Anibarro L, Vidal R, Esteban J, Blanquer R, et al. Documento de consenso sobre diagnóstico, tratamiento y prevención de la tuberculosis. Enferm Infecc Microbiol Clin. 2010;28:e1-297-20. http://dx.doi.org/10.1016/j.eimc.2010.02.006.; Agudelo C, Builes L, Hernández M, Robledo J. Nuevos métodos para el diagnóstico del tuberculosis. Iatreia. 2008;21:321-32.; Marlowe EM, Novak-Weekley SM, Cumpio J, Sharp SE, Momeny MA, Babst A, et al. Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J Clin Microbiol. 2011;49:1621-3. http://dx.doi.org/10.1128/JCM.02214-10.; Centers for Disease Control and Prevention. Testing for TB infection. 2014. Fecha de consulta: 13 de agosto de 2015. Disponible en: http://www.cdc.gov/tb/topic/testing/default.htm.; Penz E, Boffa J, Roberts DJ, Fisher D, Cooper R, Ronksley PE, et al. Diagnostic accuracy of the Xpert® MTB/RIF assay for extra-pulmonary tuberculosis: A meta-analysis. Int J Tuberc Lung Dis. 2015;19:278-84. http://dx.doi.org/10.5588/ijtld.14.0262.; World Health Organization. Xpert MTB/RIF implementation manual: Technical and operational "how-to"; practical considerations. WHO/HTM/TB/2014.1 Geneva: WHO; 2014. Fecha de consulta: 12 de agosto de 2015. Disponible en: http://who.int/tb/publications/xpert_implem_manual/en/.; Ajantha GS, Shetty PC, Kulkarni RD, Biradar U. PCR as a diagnostic tool for extra-pulmonary tuberculosis. J Clin Diagn Res. 2013;7:1012-5. http://dx.doi.org/10.7860/JCDR/2013/5425.3075.; World Health Organization. The Global Plan to Stop TB, 2006-2015. Fecha de consulta: 10 de julio de 2013. Disponible en: http://www.who.int/tb/publications/2006/en/.; https://revistabiomedica.org/index.php/biomedica/article/view/3088
-
19Book
المؤلفون: Godnick, William, Bustamante, Julián
المصدر: Gewalt, Organisierte Kriminalität und Staat in Lateinamerika ; page 101-144
-
20Academic Journal
المصدر: Policía y seguridad pública, ISSN 2225-5648, Vol. 2, Nº. 4 (Julio - Diciembre), 2014, pags. 31-79
مصطلحات موضوعية: violencia armada, tráfico de armas, armas de fuego, seguridad privada, guardias de seguridad privada
وصف الملف: application/pdf